Arbutus Biopharma Corporation - ABUS

About Gravity Analytica
Recent News
- 04.23.2025 - Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
- 04.23.2025 - Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
- 04.23.2025 - Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
- 03.27.2025 - Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
- 03.27.2025 - Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
- 03.27.2025 - Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Recent Filings
- 04.21.2025 - 144 Report of proposed sale of securities
- 04.15.2025 - 144 Report of proposed sale of securities
- 04.04.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 04.04.2025 - DEF 14A Other definitive proxy statements
- 04.03.2025 - 8-K Current report
- 04.01.2025 - 4/A Statement of changes in beneficial ownership of securities
- 03.31.2025 - 144 Report of proposed sale of securities
- 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.31.2025 - 3 Initial statement of beneficial ownership of securities
- 03.27.2025 - 8-K Current report